RHYTHM PHARMACEUTICALS CEO David P. Meeker exercised Options for 50,000 shares at $6.05 per share on 2026-09-14. He then sold 50,000 shares across five transactions priced from $101.75 to $105.19, leaving 239,258 shares, while a derivative-security holding stood at 15,431. The sequence changed his reported holdings.

Key Highlights

  • David P. Meeker sold 50,000 RHYTHM PHARMACEUTICALS shares across five transactions priced from $101.75 to $105.19 per share.
  • Meeker held 239,258 RHYTHM PHARMACEUTICALS shares after the sales.
  • His derivative-security holding stood at 15,431 after the option exercise, representing about 76.4% of his prior holding.

RHYTHM PHARMACEUTICALS, INC. (NASDAQ: RYTM) CEO David P. Meeker exercised options for 50,000 shares at $6.05 per share on 14 September 2026. The transaction was followed by sales of the same number of shares across five transactions at prices ranging from $101.75 to $105.19 per share.

The option exercise carried transaction code M. Meeker’s share ownership reached 289,258 after that transaction, and the exercise represented about 17.3% of his resulting share holding. The subsequent sales carried transaction code S. After those transactions, Meeker owned 239,258 RHYTHM PHARMACEUTICALS shares.

Derivative Securities and Reported Holdings

The transaction records also show an exercise involving 50,000 derivative securities. Meeker held 15,431 derivative securities after that transaction. The exercised amount represented about 76.4% of his prior derivative-securities holding. The transaction codes used here mean: M denotes the exercise or conversion of a derivative security; S denotes an open-market or private sale.